Twinrab 1500Iu/2.5Ml Inj

Twinrab 1500Iu/2.5Ml Inj is a combination medicine that belongs to the class of monoclonal antibodies. It is used in post-exposure rabies prophylaxis (prevention). Rabies is a viral disease spread through contact with infected animal saliva, usually through bites, scratches, or licks on broken skin. Symptoms include pain or itching at the bite site, fever, fear of water, and sensitivity to noise, light, and air.

Twinrab 1500Iu/2.5Ml Inj contains Docaravimab and Miromavimab as its active components. It works by binding to the rabies virus and neutralizing it, providing immediate passive immunity to individuals exposed to the virus.

Twinrab 1500Iu/2.5Ml Inj will be administered by a healthcare professional; do not self-administer. Common side effects of Twinrab 1500Iu/2.5Ml Inj include injection site reactions such as pain, swelling, redness, and a low-grade fever. Most of these side effects do not require medical attention and gradually resolve over time. However, please contact your doctor if these side effects persist or worsen.

Before starting treatment with Twinrab 1500Iu/2.5Ml Inj, inform your doctor if you are allergic to any of its components. Consult your doctor if you are breastfeeding or pregnant. Twinrab 1500Iu/2.5Ml Inj is recommended for children and older adults only if prescribed by a doctor, as its effects are not fully established. Let your doctor know if you have any pre-existing medical conditions or liver/kidney diseases before receiving Twinrab 1500Iu/2.5Ml Inj.

Twinrab 1500Iu/2.5Ml Inj is used in post-exposure rabies prevention. The detailed uses of Twinrab 1500Iu/2.5Ml Inj are as follows:

• Prevention of post-exposure rabies: Twinrab 1500Iu/2.5Ml Inj is used for post-exposure rabies prevention.
• Prevents clinical symptoms: Twinrab 1500Iu/2.5Ml Inj helps prevent clinical symptoms and fatal progression of rabies.

• Follow your doctor’s instructions on the dosage and timing of this medication.
• Twinrab 1500Iu/2.5Ml Inj is administered by the doctor or healthcare professional.
• Do not self-administer.

Twinrab 1500Iu/2.5Ml Inj is a combination medicine belonging to the monoclonal antibody class. It is used in post-exposure rabies prophylaxis (prevention). Twinrab 1500Iu/2.5Ml Inj contains Docaravimab and Miromavimab, which bind to the rabies virus and neutralize it, providing immediate passive immunity to individuals exposed to it.

Before starting treatment with Twinrab 1500Iu/2.5Ml Inj, inform your doctor if you are allergic to any of its active components. Also, discuss all your health conditions and the medications you are taking with your doctor to avoid potential interactions. Inform your doctor before receiving Twinrab 1500Iu/2.5Ml Inj if you are pregnant, planning to become pregnant, or breastfeeding. Additionally, caution is needed when giving this treatment to children or older adults, only if advised by a medical professional. Be careful if combining Twinrab 1500Iu/2.5Ml Inj with other medications or vaccines. Therefore, always consult a doctor before starting Twinrab 1500Iu/2.5Ml Inj.